Applied Therapeutics (APLT)
(Delayed Data from NSDQ)
$0.43 USD
-0.01 (-2.36%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.44 +0.01 (1.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Applied Therapeutics Inc. has a market cap of $64.11M, which represents its share price of $0.45 multiplied by its outstanding shares number of 144.01M. As a small-cap company, APLT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
APLT 0.43 -0.01(-2.36%)
Will APLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APLT
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates
APLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
Company News for Dec 2, 2024
Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More
Other News for APLT
APLT forms Non-ADX 1,2,3,4 Bearish on September 18
Is APLT building bearish momentum? 180 Bearish Setup shows up after slipping 4.35%
Is APLT preparing to trend higher? Bullish Engulfing shows up after gaining 3.37%
APLT forms Lower Bollinger Band Walk on September 15
APLT falls 4.71% on September 12, leaving the technical picture intact